The Daily Express leads with a new Alzheimer’s drug that has been proven to slow the disease by more than a third, in patients with early symptoms.
Writing in the paper, doctor Richard Oakley from the Alzheimer’s Society says the success of the medicine, called Donanemab, means “we are at the beginning of the end” of the condition.
The paper says the finding provides “real hope” in the battle against the disease and quotes Dr Susan Kohlhaas, director of research at Alzheimer’s Research UK, calling it a “hugely significant moment”.
‘In both games I think we played better than United.’
Like this article?
WTX News Editor
The WTX News Teams works around the clock to deliver, breaking news and news Briefings to you on a daily basis. It is our opinion that sometimes you need information, not speculation so we try to cut through the bull**** and give you that in your Daily News Briefing.